ADVFN US – Market Content Editor

Shares of Travere Therapeutics Inc (NASDAQ:TVTX) jumped 8.8% after the U.S. Food and Drug Administration approved revised monitoring guidelines for its kidney disease therapy FILSPARI. The FDA has reduced the required liver function checks for patients on FILSPARI from monthly to once every three months. Additionally, the agency eliminated the embryo-fetal toxicity monitoring requirement from…

Agrify Corporation (NASDAQ:AGFY) saw its stock leap 50% after the company announced it had purchased a portfolio of brand intellectual properties from Green Thumb Industries for $50 million, funded via a convertible note. The deal includes well-known cannabis brands such as RYTHM, Dogwalkers, and Beboe. Under the agreement, Agrify will license the brands back to…

SharkNinja Inc. (NYSE:SN) saw its stock decline about 5% on Thursday following news that Chief Financial Officer Patraic Reagan will step down, effective September 5, 2025. According to a Securities and Exchange Commission filing, Reagan informed the company of his decision on August 26. SharkNinja stressed that his resignation is unrelated to any disputes or…

CaliberCos Inc (NASDAQ:CWD) stock jumped roughly 80% following the announcement that the company’s Board of Directors has approved a digital asset treasury strategy centered on acquiring LINK tokens, which are used in the Chainlink protocol. Under the new plan, Caliber will allocate part of its treasury to purchase cryptocurrency, with an initial focus on LINK…

Snowflake Inc. (NYSE:SNOW) shares jumped roughly 14% in early trading Thursday after the cloud data platform provider reported second-quarter results that surpassed analyst expectations and increased its full-year product revenue outlook. The company posted $1.14 billion in quarterly revenue, beating the consensus estimate of $1.09 billion and reflecting a 32% year-over-year increase. Product revenue, which…

Celcuity Inc. (NASDAQ:CELC) stock jumped 9.3% following the announcement that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for gedatolisib in HR+/HER2- advanced breast cancer. The submission will be reviewed under the FDA’s Real-Time Oncology Review (RTOR) program. The RTOR initiative allows companies to submit key efficacy and safety…

Teva Pharmaceutical Industries Ltd ADR (NYSE:TEVA) saw its stock climb 2.7% after announcing FDA approval and the U.S. launch of its generic version of Saxenda (liraglutide injection). This marks the first generic GLP-1 drug specifically approved for weight loss. The new liraglutide injection addresses rising demand for weight management therapies in the United States. It…

Telomir Pharmaceuticals Inc (NASDAQ:TELO) saw its stock jump 38% following the announcement of encouraging in vitro results for its lead drug candidate, Telomir-1. The data revealed that the compound effectively inhibits UTX (KDM6A), an enzyme long deemed “undruggable” and linked to cancer and aging. The preclinical-stage biotech firm reported that Telomir-1 potently blocks UTX, which…

Telix Pharmaceuticals Ltd ADR (NASDAQ:TLX) saw its stock plummet 19% in premarket trading Thursday following the announcement that the U.S. Food and Drug Administration issued a Complete Response Letter (CRL) for its investigational PET imaging agent, TLX250-CDx. The FDA highlighted issues in the Chemistry, Manufacturing, and Controls (CMC) section of the TLX250-CDx (Zircaix) application, which…

Malibu Boats, Inc. (NASDAQ:MBUU) saw its shares drop 6.38% in pre-market trading Thursday after reporting strong fourth-quarter results but providing a conservative outlook for fiscal 2026. The recreational boatmaker posted Q4 net sales of $207 million, a 30.4% increase from a year ago, well above analyst expectations of $178.2 million. Adjusted earnings per share came…